Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancer.
Breast Cancer Research and Treatment.
Times cited: 3
Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: Randomized phase II study.
Annals of Oncology.
Times cited: 40